BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Croce S, Hostein I, McCluggage WG. NTRK and other recently described kinase fusion positive uterine sarcomas: A review of a group of rare neoplasms. Genes Chromosomes Cancer 2021;60:147-59. [PMID: 33099837 DOI: 10.1002/gcc.22910] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Yin L, Shi C, He X, Qiu Y, Chen H, Chen M, Zhang Z, Chen Y, Zhou Y, Zhang H. NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China. Pathology 2023;55:362-74. [PMID: 36641377 DOI: 10.1016/j.pathol.2022.10.003] [Reference Citation Analysis]
2 Lu L, Wang S, Shen H, Zhang F, Ma F, Shi Y, Ning Y. Case Report: A case of COL1A1–PDGFB fusion uterine sarcoma at cervix and insights into the clinical management of rare uterine sarcoma. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1108586] [Reference Citation Analysis]
3 Hogeboom A, Bárcena C, Parrilla-Rubio L, Revilla E, Ruano Y, Gallego-Gutiérrez I, Martínez-López M. A Case of COL1A1-PDGFB Fusion Uterine Sarcoma. Int J Gynecol Pathol 2023;42:147-50. [PMID: 35551153 DOI: 10.1097/PGP.0000000000000875] [Reference Citation Analysis]
4 Wu G, Guo W, Zhu S, Fan G. Single-Cell and Transcriptome-Based Immune Cell-Related Prognostic Model in Clear Cell Renal Cell Carcinoma. J Oncol 2023;2023:5355269. [PMID: 36925653 DOI: 10.1155/2023/5355269] [Reference Citation Analysis]
5 Nucci MR, Webster F, Croce S, George S, Howitt BE, Ip PP, Lee C, Rabban JT, Soslow RA, van der Griend R, Lax SF, Mccluggage WG. Data Set for Reporting of Uterine Malignant and Potentially Malignant Mesenchymal Tumors: Recommendations From the International Collaboration on Cancer Reporting (ICCR). International Journal of Gynecological Pathology 2022;41:S44-S63. [DOI: 10.1097/pgp.0000000000000911] [Reference Citation Analysis]
6 Croce S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, Treilleux I, Neuville A, Arnould L, Just PA, Belda MALF, Averous G, Leroux A, Mery E, Loussouarn D, Weinbreck N, Le Guellec S, Mishellany F, Morice P, Guyon F, Genestie C. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group. Gynecol Oncol 2022:S0090-8258(22)00515-7. [PMID: 36114030 DOI: 10.1016/j.ygyno.2022.07.031] [Reference Citation Analysis]
7 Marchetti A, Ferro B, Pasciuto MP, Zampacorta C, Buttitta F, D'Angelo E. NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategies. Pathologica 2022;114:199-216. [PMID: 35775706 DOI: 10.32074/1591-951X-787] [Reference Citation Analysis]
8 Mosaieby E, Martínek P, Ondič O. The significance of the fusion partner gene genomic neighborhood analysis in translocation-defined tumors. Mol Genet Genomic Med 2022;:e1994. [PMID: 35621010 DOI: 10.1002/mgg3.1994] [Reference Citation Analysis]
9 Dang X, Xiang T, Zhao C, Tang H, Cui P. EML4-NTRK3 Fusion Cervical Sarcoma: A Case Report and Literature Review. Front Med (Lausanne) 2022;9:832376. [PMID: 35572973 DOI: 10.3389/fmed.2022.832376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Agaimy A, Clarke BA, Kolin DL, Lee CH, Lee JC, McCluggage WG, Pöschke P, Stoehr R, Swanson D, Turashvili G, Beckmann MW, Hartmann A, Antonescu CR, Dickson BC. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma. Am J Surg Pathol 2022. [PMID: 35575789 DOI: 10.1097/PAS.0000000000001915] [Reference Citation Analysis]
11 Croce S, Perret R, Le Loarer F. Update on Mesenchymal Lesions of the Lower Female Genital Tract. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.02.009] [Reference Citation Analysis]
12 Niu S, Zheng W. Endometrial stromal tumors: Diagnostic updates and challenges. Seminars in Diagnostic Pathology 2022. [DOI: 10.1053/j.semdp.2022.01.004] [Reference Citation Analysis]
13 McCluggage WG. Progress in the pathological arena of gynecological cancers. Int J Gynaecol Obstet 2021;155 Suppl 1:107-14. [PMID: 34669206 DOI: 10.1002/ijgo.13871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Dieckmann N, Schildhaus HU, Bauer S. Tropomyosin receptor kinases in sarcomas - of joy and despair. Curr Opin Oncol 2021;33:336-44. [PMID: 33989242 DOI: 10.1097/CCO.0000000000000752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Bennett JA, Wang P, Wanjari P, Diaz L, Oliva E. Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion. Genes Chromosomes Cancer 2021. [PMID: 34322931 DOI: 10.1002/gcc.22986] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]